Professionals in partnership.
The Entrepreneurs Fund team brings broad experience gained from investing in widely differing territories, sectors and phases.
Dennis Brenninkmeijer. Partner. Joined 2004.
Educated at the European Business School in London, Dennis had an 18 year career in clothing retail that saw him become Procurement Director in South America before working at ABN AMRO at Associate level as an investment manager.
Educated at the European Business School in London, Dennis had an 18 year career in clothing retail that saw him become Procurement Director in South America before working at ABN AMRO at Associate level as an investment manager.
Klaas de Boer. Managing Partner. Joined 2006.
Klaas has more than 10 years of venture experience. It started when he created and led a corporate venturing team at Vanenburg Group whose investments included WebEx. Prior to this, he spent time as a consultant with McKinsey and Company in both Amsterdam and St Petersburg. Behind Klaas’ achievements are an MSc in Physics and an Insead MBA.
Klaas has more than 10 years of venture experience. It started when he created and led a corporate venturing team at Vanenburg Group whose investments included WebEx. Prior to this, he spent time as a consultant with McKinsey and Company in both Amsterdam and St Petersburg. Behind Klaas’ achievements are an MSc in Physics and an Insead MBA.
Maciek Drozdz. Investment Manager. Joined 2008.
Maciek joined the Entrepreneurs Fund from MCI.BioVentures. Prior to that he was an analyst at AtlasVenture. Maciek holds an MSc in molecular biology from A. Mickiewicz University, and a PhD from Zentrum fuer Molekulare Biologie in Heidelberg. He also has an MBA from Said Business School.
Maciek joined the Entrepreneurs Fund from MCI.BioVentures. Prior to that he was an analyst at AtlasVenture. Maciek holds an MSc in molecular biology from A. Mickiewicz University, and a PhD from Zentrum fuer Molekulare Biologie in Heidelberg. He also has an MBA from Said Business School.
Martin Hopson. Controller. Joined 2005.
Qualified as a Chartered Account with Deloitte & Touche and with an MBA from City University Business School, Martin brings wide experience of finance and operations in small and medium sized companies in the telecoms and software sectors.
Qualified as a Chartered Account with Deloitte & Touche and with an MBA from City University Business School, Martin brings wide experience of finance and operations in small and medium sized companies in the telecoms and software sectors.
Sally Nilsson. Legal Counsel. Joined 2007.
With qualifications from Bristol University and Nottingham Law School, Sally comes to Entrepreneurs Fund after more than 5 years with Clifford Chance LLP’s practice in London.
With qualifications from Bristol University and Nottingham Law School, Sally comes to Entrepreneurs Fund after more than 5 years with Clifford Chance LLP’s practice in London.
Alexander Hardtmuth. Associate. Joined 2008.
Alex was previously an Associate at AnaCap Financial Partners, a London-based Private Equity fund. Before that he was a consultant with Arthur Andersen and KPMG.
Alex holds an MSc Finance degree from LBS, and an MSc in Industrial Engineering from ETH Zurich.
Alex was previously an Associate at AnaCap Financial Partners, a London-based Private Equity fund. Before that he was a consultant with Arthur Andersen and KPMG.
Alex holds an MSc Finance degree from LBS, and an MSc in Industrial Engineering from ETH Zurich.
Martina Griffin. PA. Joined 2008.
Grew up in Singapore and has been in the UK since 2000. Martina speaks Japanese and Mandarin.
Grew up in Singapore and has been in the UK since 2000. Martina speaks Japanese and Mandarin.
Peter Dudek. Associate. Joined 2011.
Peter previously worked with Novartis Venture Funds as an analyst intern and consulted for biotech companies in the biological therapeutics space. Prior to that he was a researcher at the University of Oxford.
Peter holds a PhD in molecular biology from the University of Geneva and a BSc (Hons) from the University of British Columbia.
Peter previously worked with Novartis Venture Funds as an analyst intern and consulted for biotech companies in the biological therapeutics space. Prior to that he was a researcher at the University of Oxford.
Peter holds a PhD in molecular biology from the University of Geneva and a BSc (Hons) from the University of British Columbia.
